Trial intelligence / Profile preview

IV Meloxicam vs Ketorolac for Pain Post TJA

NCT05291598Phase 3Completed

Sponsor
University of Miami
Start
May 2022
Primary completion
May 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of meloxicam in postoperative pain, sponsored by University of Miami. Started May 2022; status: completed.

02

Drugs

meloxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05291598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05291598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call